Home Xenikos

Xenikos

Out of service
-
Drug Developer

Basic Information

Xenikos is developing a new therapy that enables patients with severe immune disorders or post-transplant rejection to quickly and effectively reset their immune systems. Xenikos' mission is to develop novel, innovative immunotherapeutic drugs to help restore patients' health and save lives.
Xenikos B.V.
Nijmegen,Gelderland,Netherlands
less than 15 people
January 01, 2009
info@xenikos.com